Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articul...
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)
About this item
Full title
Author / Creator
Hørslev-Petersen, K , Hetland, M L , Ørnbjerg, L M , Junker, P , Pødenphant, J , Ellingsen, T , Ahlquist, P , Lindegaard, H , Linauskas, A , Schlemmer, A , Dam, M Y , Hansen, I , Lottenburger, T , Ammitzbøll, C G , Jørgensen, A , Krintel, S B , Raun, J , Johansen, J S , Østergaard, M , Stengaard-Pedersen, K and OPERA Study-Group
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
ObjectivesTo study clinical and radiographic outcomes after withdrawing 1 year's adalimumab induction therapy for early rheumatoid arthritis (eRA) added to a methotrexate and intra-articular triamcinolone hexacetonide treat-to-target strategy (NCT00660647).MethodsDisease-modifying antirheumatic drug (DMARD)-naive patients with eRA started methotrex...
Alternative Titles
Full title
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1815708763
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1815708763
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-208166
